ACC: Bempedoic Acid Cuts Cardiovascular Event Risk in Statin-Intolerant
Those receiving bempedoic acid had greater reduction in LDL cholesterol and significantly lower incidence of composite of major adverse cardiovascular events
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.